161 related articles for article (PubMed ID: 2331854)
1. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
Durazo F; Resano F; Gonzalez MA
Diagn Microbiol Infect Dis; 1990; 13(1):71-5. PubMed ID: 2331854
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
Wright DN; Saxon B; Matsen JM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
Torres JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
[TBL] [Abstract][Full Text] [Related]
4. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
5. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
[TBL] [Abstract][Full Text] [Related]
6. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
[TBL] [Abstract][Full Text] [Related]
7. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA
Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
Sonstein SA; Dahlgren J
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
Jones RN
J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
[No Abstract] [Full Text] [Related]
10. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
11. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of lomefloxacin (NY-198 or SC 47111).
Shah PM; Müller S; Kipp J; Stille W
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
Sun ZM; Maskell JP; Sehgal SC; Williams JD
Infection; 1989; 17(3):165-7. PubMed ID: 2737760
[TBL] [Abstract][Full Text] [Related]
14. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
Aldridge KE; Henderberg A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
DiVincenzo CA; Shatzer KL; Venezio FR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
[TBL] [Abstract][Full Text] [Related]
17. [Studies of lomefloxacin in biliary tract infections].
Ono Y; Kunii O
Jpn J Antibiot; 1989 Apr; 42(4):1017-24. PubMed ID: 2769934
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
Molinari G; Bandelloni R; Paglia P; Debbia E; Schito GC
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):53S-56S. PubMed ID: 2791499
[TBL] [Abstract][Full Text] [Related]
20. Lomefloxacin: microbiologic assessment and unique properties.
Mayer KH; Ellal JA
Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
